Cancer Research Meeting Calendar  EMT and Cancer Progression and Treatment
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

Cancer Research 67, 1793, February 15, 2007. doi: 10.1158/0008-5472.CAN-06-2678
© 2007 American Association for Cancer Research

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Brookes, P. S.
Right arrow Articles by Bernstein, S. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Brookes, P. S.
Right arrow Articles by Bernstein, S. H.

Experimental Therapeutics, Molecular Targets, and Chemical Biology

The Triterpenoid 2-Cyano-3,12-dioxooleana-1,9-dien-28-oic Acid and Its Derivatives Elicit Human Lymphoid Cell Apoptosis through a Novel Pathway Involving the Unregulated Mitochondrial Permeability Transition Pore

Paul S. Brookes1, Kimberly Morse2, Denise Ray3, Andrew Tompkins1, Sara M. Young1, Shannon Hilchey2, Suhail Salim2, Marina Konopleva5, Michael Andreeff5, Richard Phipps3 and Steven H. Bernstein2,4

1 Department of Anesthesiology, 2 James P. Wilmot Cancer Center, 3 Lung Biology and Disease Program, and 4 Lymphoma Biology Program, University of Rochester Medical Center, Rochester, New York; and 5 Molecular Hematology and Therapy, University of Texas M. D. Anderson Cancer Center, Houston, Texas

Requests for reprints: Steven H. Bernstein, Lymphoma Biology Program, James P. Wilmot Cancer Center, Box 704, University of Rochester Medical Center, 601 Elmwood Avenue, Rochester, NY 14642. Phone: 585-275-3504; Fax: 585-276-0337; E-mail: steven_bernstein{at}urmc.rochester.edu.

2-Cyano-3,12-dioxooleana-1,9-dien-28-oic acid (CDDO) and its C28 imidazole and dinitrile derivatives are novel oleanane triterpenoids exhibiting promise as both therapeutic and preventative agents for cancer. Herein we show that these triterpenoids induce normal and malignant B-lymphoid cell apoptosis, with the C28 derivatives being more potent than CDDO, through a novel mitochondrial mechanism. We show using both normal and malignant human B cells, as well as isolated rat mitochondria, that CDDO directly interacts with a limited number of as yet undefined mitochondrial proteins. Such an interaction results in the loss of mitochondrial thiol status and the secondary modification of numerous mitochondrial protein thiols. Our data further suggest that such modifications result in the formation of high molecular weight protein aggregates that form "unregulated," constitutively open, cyclosporin A–insensitive permeability transition (PT) pores. The formation of such PT pores results in the subsequent generation of mitochondrial superoxide and cell death. In total, our studies (a) suggest a novel mechanism of action for triterpenoid-induced cell death; (b) are among the first to directly support the existence of an unregulated PT pore formed by mitochondrial protein aggregates, as first proposed by Lemasters and colleagues; and (c) validate such an unregulated PT pore as a viable target for the development of new cancer therapeutics. [Cancer Res 2007;67(4):1793–802]




This article has been cited by other articles:


Home page
J. Immunol.Home page
S. L. Bissonnette, J. E. Teague, D. H. Sherr, and J. J. Schlezinger
An Endogenous Prostaglandin Enhances Environmental Phthalate-Induced Apoptosis in Bone Marrow B Cells: Activation of Distinct but Overlapping Pathways
J. Immunol., August 1, 2008; 181(3): 1728 - 1736.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
M. L. Hyer, R. Shi, M. Krajewska, C. Meyer, I. V. Lebedeva, P. B. Fisher, and J. C. Reed
Apoptotic Activity and Mechanism of 2-Cyano-3,12-Dioxoolean-1,9-Dien-28-Oic-Acid and Related Synthetic Triterpenoids in Prostate Cancer
Cancer Res., April 15, 2008; 68(8): 2927 - 2933.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
J. J. Schlezinger, J. K. Emberley, S. L. Bissonnette, and D. H. Sherr
An L-Tyrosine Derivative and PPAR{gamma} Agonist, GW7845, Activates a Multifaceted Caspase Cascade in Bone Marrow B Cells
Toxicol. Sci., July 1, 2007; 98(1): 125 - 136.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2007 by the American Association for Cancer Research.